Albert Marten Schulte
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Albert Marten Schulte has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Wiktor Szymanski
Department of Medicinal Chemistry Photopharmacology and Imaging Groningen Research Institute of Pharmacy University of Groningen Groningen the Netherlands
15 shared publications - Ben Lucas Feringa
Stratingh Institute for Chemistry University of Groningen Groningen The Netherlands
12 shared publications - Georgios Alachouzos
Centre for Systems Chemistry, Stratingh Institute for Chemistry, Faculty for Science and Engineering, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands
7 shared publications Quentin Vivien
Department of Medicinal Chemistry, Photopharmacology and Imaging, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands
3 shared publicationsBart Cornelissen
Department of Nuclear Medicine and Molecular Imaging University Medical Center Groningen University of Groningen Groningen the Netherlands
2 shared publications- Francesca Amoroso
Department of Nuclear Medicine and Molecular Imaging University Medical Center Groningen University of Groningen Groningen the Netherlands
2 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by Wiley in Angewandte Chemie International Edition
- p. e9775095
Engineering Rapid Payload Release Rate in 1,6‐Elimination Processes of Self‐Immolative Linkers
Stimuli‐responsive prodrugs form the foundation of targeted medicine. These compounds, once activated at the site of interest, release their bioactive payload, often through elimination from self‐immolative linkers (SILs). However, payload release rates from activated SILs can vary widely depending on the SIL's (electronic) structure. Low release rates do not compete with diffusion of the activated prodrug from the target site, which compromises the spatial resolution and diminishes the practical utility. Here we report a new strategy to engineer the payload release rate from SILs through the introduction of cation‐stabilizing substituents, which yields an up to 10 4 ‐fold improvement in rate constant compared to the reference SIL. Relating the DFT‐computed stabilities of an ion pair intermediate with the first order rate constants for self‐immolation revealed a strong correlation, providing a robust rational basis for our strategy. Furthermore, we discovered that lipophilicity of the SIL‐payload conjugate is a key, and hitherto overlooked, factor affecting the rate, based on which we propose a new model for the overall payload release reaction. Lastly, we show the practical utility of our strategy, through demonstrating the superiority of our SILs in releasing the anticancer drug palbociclib and studying radiation‐dependent enzyme inhibition and cell‐cycle alteration.
- 30 October 2026
- Published by Wiley in Angewandte Chemie International Edition
- p. e9775095
Open AccessEngineering Rapid Payload Release Rate in 1,6‐Elimination Processes of Self‐Immolative Linkers
Stimuli‐responsive prodrugs form the foundation of targeted medicine. These compounds, once activated at the site of interest, release their bioactive payload, often through elimination from self‐immolative linkers (SILs). However, payload release rates from activated SILs can vary widely depending on the SIL's (electronic) structure. Low release rates do not compete with diffusion of the activated prodrug from the target site, which compromises the spatial resolution and diminishes the practical utility. Here we report a new strategy to engineer the payload release rate from SILs through the introduction of cation‐stabilizing substituents, which yields an up to 10 4 ‐fold improvement in rate constant compared to the reference SIL. Relating the DFT‐computed stabilities of an ion pair intermediate with the first order rate constants for self‐immolation revealed a strong correlation, providing a robust rational basis for our strategy. Furthermore, we discovered that lipophilicity of the SIL‐payload conjugate is a key, and hitherto overlooked, factor affecting the rate, based on which we propose a new model for the overall payload release reaction. Lastly, we show the practical utility of our strategy, through demonstrating the superiority of our SILs in releasing the anticancer drug palbociclib and studying radiation‐dependent enzyme inhibition and cell‐cycle alteration.
- Open Access
- 29 October 2026
- Published by Wiley in Angewandte Chemie
Engineering Rapid Payload Release Rate in 1,6‐Elimination Processes of Self‐Immolative Linkers
Stimuli‐responsive prodrugs form the foundation of targeted medicine. These compounds, once activated at the site of interest, release their bioactive payload, often through elimination from self‐immolative linkers (SILs). However, payload release rates from activated SILs can vary widely depending on the SIL's (electronic) structure. Low release rates do not compete with diffusion of the activated prodrug from the target site, which compromises the spatial resolution and diminishes the practical utility. Here we report a new strategy to engineer the payload release rate from SILs through the introduction of cation‐stabilizing substituents, which yields an up to 10 4 ‐fold improvement in rate constant compared to the reference SIL. Relating the DFT‐computed stabilities of an ion pair intermediate with the first order rate constants for self‐immolation revealed a strong correlation, providing a robust rational basis for our strategy. Furthermore, we discovered that lipophilicity of the SIL‐payload conjugate is a key, and hitherto overlooked, factor affecting the rate, based on which we propose a new model for the overall payload release reaction. Lastly, we show the practical utility of our strategy, through demonstrating the superiority of our SILs in releasing the anticancer drug palbociclib and studying radiation‐dependent enzyme inhibition and cell‐cycle alteration.
- 29 October 2026
- Published by Wiley in Angewandte Chemie
Open AccessEngineering Rapid Payload Release Rate in 1,6‐Elimination Processes of Self‐Immolative Linkers
Stimuli‐responsive prodrugs form the foundation of targeted medicine. These compounds, once activated at the site of interest, release their bioactive payload, often through elimination from self‐immolative linkers (SILs). However, payload release rates from activated SILs can vary widely depending on the SIL's (electronic) structure. Low release rates do not compete with diffusion of the activated prodrug from the target site, which compromises the spatial resolution and diminishes the practical utility. Here we report a new strategy to engineer the payload release rate from SILs through the introduction of cation‐stabilizing substituents, which yields an up to 10 4 ‐fold improvement in rate constant compared to the reference SIL. Relating the DFT‐computed stabilities of an ion pair intermediate with the first order rate constants for self‐immolation revealed a strong correlation, providing a robust rational basis for our strategy. Furthermore, we discovered that lipophilicity of the SIL‐payload conjugate is a key, and hitherto overlooked, factor affecting the rate, based on which we propose a new model for the overall payload release reaction. Lastly, we show the practical utility of our strategy, through demonstrating the superiority of our SILs in releasing the anticancer drug palbociclib and studying radiation‐dependent enzyme inhibition and cell‐cycle alteration.
- Open Access
- 24 June 2026
- Published by Springer Nature in Nature Chemical Biology
- Vol. 22 (7) , 1044-1056
Image-guided activation of drugs with electromagnetic radiation
Image-guided pharmacotherapy, in which drug activity is strictly confined to disease areas revealed by medical imaging modalities, holds great promise for the development of personalized medicine. A key step in realizing this potential is the development of safe and precise methods for drug activation. Electromagnetic radiation, spanning the energy ranges from γ-rays to ultraviolet–visible and infrared light, has emerged as a method of choice for this purpose. Because many imaging modalities rely on electromagnetic radiation to generate signals (for example, optical and optoacoustic imaging, computed tomography and positron emission tomography), this phenomenon can be used to both activate a drug and monitor tissue response, creating a theranostic synergy. This Perspective outlines the molecular basis for drug activation with electromagnetic radiation, offers a clinical perspective in discussing the most suitable applications and advantages available and discusses the challenges, such as the delivery of light at the site of interest, and steps needed for successful translation into daily clinical practice.
- 24 June 2026
- Published by Springer Nature in Nature Chemical Biology
- Vol. 22 (7) , 1044-1056
Open AccessImage-guided activation of drugs with electromagnetic radiation
Image-guided pharmacotherapy, in which drug activity is strictly confined to disease areas revealed by medical imaging modalities, holds great promise for the development of personalized medicine. A key step in realizing this potential is the development of safe and precise methods for drug activation. Electromagnetic radiation, spanning the energy ranges from γ-rays to ultraviolet–visible and infrared light, has emerged as a method of choice for this purpose. Because many imaging modalities rely on electromagnetic radiation to generate signals (for example, optical and optoacoustic imaging, computed tomography and positron emission tomography), this phenomenon can be used to both activate a drug and monitor tissue response, creating a theranostic synergy. This Perspective outlines the molecular basis for drug activation with electromagnetic radiation, offers a clinical perspective in discussing the most suitable applications and advantages available and discusses the challenges, such as the delivery of light at the site of interest, and steps needed for successful translation into daily clinical practice.
- Open Access
- 11 June 2025
- Published by American Chemical Society (ACS) in ACS Central Science
- Vol. 11 (7) , 1083-1093
Green-Light-Activatable Penicillin for Light-Dependent Spatial Control of Bacterial Growth, Biofilm Formation, and In Vivo Infection Treatment
Our ability to prevent, treat, and cure bacterial infections is nowadays seriously threatened by the rise of (multidrug) antimicrobial resistance (AMR), and novel molecular approaches in the antibacterial arsenal are urgently needed. To fight the development of AMR, the field of photopharmacology aims to develop photoresponsive antimicrobials allowing for noninvasive activation of the drug only at the site needed, with spatiotemporal precision, reducing the bacterial exposure to the active antimicrobial in the environment. This study reports the development and application for the first time of a green-light-activatable variant of penicillin (Penicillin-PPG), designed through the incorporation of a photocleavable protecting group. Here, we demonstrate that Penicillin-PPG shows no antimicrobial activity in the dark, while it can be precisely activated through irradiation with green light. Furthermore, we show Penicillin-PPG's utility to spatially control bacterial growth, achieve light-dependent inhibition of biofilm formation, and showcase the unprecedented usage of a photoactivatable antimicrobial in vivo in a small animal infection model. Furthermore, we apply Penicillin-PPG in combination with a λ-orthogonally photocaged bioactive compound to achieve photocontrol over antimicrobial activity dependent on two distinct colors of light.
- 11 June 2025
- Published by American Chemical Society (ACS) in ACS Central Science
- Vol. 11 (7) , 1083-1093
Open AccessGreen-Light-Activatable Penicillin for Light-Dependent Spatial Control of Bacterial Growth, Biofilm Formation, and In Vivo Infection Treatment
Our ability to prevent, treat, and cure bacterial infections is nowadays seriously threatened by the rise of (multidrug) antimicrobial resistance (AMR), and novel molecular approaches in the antibacterial arsenal are urgently needed. To fight the development of AMR, the field of photopharmacology aims to develop photoresponsive antimicrobials allowing for noninvasive activation of the drug only at the site needed, with spatiotemporal precision, reducing the bacterial exposure to the active antimicrobial in the environment. This study reports the development and application for the first time of a green-light-activatable variant of penicillin (Penicillin-PPG), designed through the incorporation of a photocleavable protecting group. Here, we demonstrate that Penicillin-PPG shows no antimicrobial activity in the dark, while it can be precisely activated through irradiation with green light. Furthermore, we show Penicillin-PPG's utility to spatially control bacterial growth, achieve light-dependent inhibition of biofilm formation, and showcase the unprecedented usage of a photoactivatable antimicrobial in vivo in a small animal infection model. Furthermore, we apply Penicillin-PPG in combination with a λ-orthogonally photocaged bioactive compound to achieve photocontrol over antimicrobial activity dependent on two distinct colors of light.
- Open Access
- 9 May 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (23) , 10585-10594
Photo-amygdalin: light-dependent control over hydrogen cyanide release and cytotoxicity
A photoresponsive analogue of amygdalin enables light-dependent control over hydrogen cyanide release, myoglobin cyanide binding and cytotoxicity.
- 9 May 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (23) , 10585-10594
Open AccessPhoto-amygdalin: light-dependent control over hydrogen cyanide release and cytotoxicity
A photoresponsive analogue of amygdalin enables light-dependent control over hydrogen cyanide release, myoglobin cyanide binding and cytotoxicity.
- Open Access
- 14 October 2024
- Published by Wiley in Angewandte Chemie
- Vol. 136 (47)
Photocleavable Protecting Groups Using a Sulfite Self‐Immolative Linker for High Uncaging Quantum Yield and Aqueous Solubility
Using light as an external stimulus to control (bio)chemical processes offers many distinct advantages. Most importantly, it allows for spatiotemporal control simply through operating the light source. Photocleavable protecting groups (PPGs) are a cornerstone class of compounds that are used to achieve photocontrol over (bio)chemical processes. PPGs are able to release a payload of interest upon light irradiation. The successful application of PPGs hinges on their efficiency of payload release, captured in the uncaging Quantum Yield (QY). Heterolytic PPGs efficiently release low pKa payloads, but their efficiency drops significantly for payloads with higher pKa values, such as alcohols. For this reason, alcohols are usually attached to PPGs via a carbonate linker. The self‐immolative nature of the carbonate linker results in concurrent release of CO2 with the alcohol payload upon irradiation. We introduce herein novel PPGs containing sulfites as self‐immolative linkers for photocaged alcohol payloads, for which we discovered that the release of the alcohol proceeds with higher uncaging QY than an identical payload released from a carbonate‐linked PPG. Furthermore, we demonstrate that uncaging of the sulfite‐linked PPGs results in the release of SO2 and show that the sulfite linker improves water solubility as compared to the carbonate‐based systems.
- 14 October 2024
- Published by Wiley in Angewandte Chemie
- Vol. 136 (47)
Open AccessPhotocleavable Protecting Groups Using a Sulfite Self‐Immolative Linker for High Uncaging Quantum Yield and Aqueous Solubility
Using light as an external stimulus to control (bio)chemical processes offers many distinct advantages. Most importantly, it allows for spatiotemporal control simply through operating the light source. Photocleavable protecting groups (PPGs) are a cornerstone class of compounds that are used to achieve photocontrol over (bio)chemical processes. PPGs are able to release a payload of interest upon light irradiation. The successful application of PPGs hinges on their efficiency of payload release, captured in the uncaging Quantum Yield (QY). Heterolytic PPGs efficiently release low pKa payloads, but their efficiency drops significantly for payloads with higher pKa values, such as alcohols. For this reason, alcohols are usually attached to PPGs via a carbonate linker. The self‐immolative nature of the carbonate linker results in concurrent release of CO2 with the alcohol payload upon irradiation. We introduce herein novel PPGs containing sulfites as self‐immolative linkers for photocaged alcohol payloads, for which we discovered that the release of the alcohol proceeds with higher uncaging QY than an identical payload released from a carbonate‐linked PPG. Furthermore, we demonstrate that uncaging of the sulfite‐linked PPGs results in the release of SO2 and show that the sulfite linker improves water solubility as compared to the carbonate‐based systems.
- Open Access
- 14 October 2024
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (47) , e202411380
Photocleavable Protecting Groups Using a Sulfite Self‐Immolative Linker for High Uncaging Quantum Yield and Aqueous Solubility
Using light as an external stimulus to control (bio)chemical processes offers many distinct advantages. Most importantly, it allows for spatiotemporal control simply through operating the light source. Photocleavable protecting groups (PPGs) are a cornerstone class of compounds that are used to achieve photocontrol over (bio)chemical processes. PPGs are able to release a payload of interest upon light irradiation. The successful application of PPGs hinges on their efficiency of payload release, captured in the uncaging Quantum Yield (QY). Heterolytic PPGs efficiently release low pKa payloads, but their efficiency drops significantly for payloads with higher pKa values, such as alcohols. For this reason, alcohols are usually attached to PPGs via a carbonate linker. The self‐immolative nature of the carbonate linker results in concurrent release of CO2 with the alcohol payload upon irradiation. We introduce herein novel PPGs containing sulfites as self‐immolative linkers for photocaged alcohol payloads, for which we discovered that the release of the alcohol proceeds with higher uncaging QY than an identical payload released from a carbonate‐linked PPG. Furthermore, we demonstrate that uncaging of the sulfite‐linked PPGs results in the release of SO2 and show that the sulfite linker improves water solubility as compared to the carbonate‐based systems.
- 14 October 2024
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (47) , e202411380
Open AccessPhotocleavable Protecting Groups Using a Sulfite Self‐Immolative Linker for High Uncaging Quantum Yield and Aqueous Solubility
Using light as an external stimulus to control (bio)chemical processes offers many distinct advantages. Most importantly, it allows for spatiotemporal control simply through operating the light source. Photocleavable protecting groups (PPGs) are a cornerstone class of compounds that are used to achieve photocontrol over (bio)chemical processes. PPGs are able to release a payload of interest upon light irradiation. The successful application of PPGs hinges on their efficiency of payload release, captured in the uncaging Quantum Yield (QY). Heterolytic PPGs efficiently release low pKa payloads, but their efficiency drops significantly for payloads with higher pKa values, such as alcohols. For this reason, alcohols are usually attached to PPGs via a carbonate linker. The self‐immolative nature of the carbonate linker results in concurrent release of CO2 with the alcohol payload upon irradiation. We introduce herein novel PPGs containing sulfites as self‐immolative linkers for photocaged alcohol payloads, for which we discovered that the release of the alcohol proceeds with higher uncaging QY than an identical payload released from a carbonate‐linked PPG. Furthermore, we demonstrate that uncaging of the sulfite‐linked PPGs results in the release of SO2 and show that the sulfite linker improves water solubility as compared to the carbonate‐based systems.
- Open Access
- 1 June 2024
- Published by Wiley in Smart Molecules
- Vol. 2 (2)
Towards medical imaging of drug photoactivation: Development of light responsive magnetic resonance imaging and chemical exchange saturation transfer contrast agents
In recent years, the use of light to selectively and precisely activate drugs has been developed along the fundamental concepts of photopharmacology. One of the key methods in this field relies on transiently silencing the drug activity with photocleavable protecting groups (PPGs). To effectively utilize light‐activated drugs in future medical applications, physicians will require a reliable method to assess whether light penetrates deep enough into the tissues to activate the photoresponsive theragnostic agents. Here, we describe the development and evaluation of magnetic resonance (MR) imaging agents that allow for the detection of light penetration and drug activation in the tissues using non‐invasive whole‐body magnetic resonance imaging (MRI) and chemical exchange saturation transfer (CEST)‐MRI modalities. The approach relies on the use of PPG‐protected MR contrast agents, which upon irradiation with light change their imaging signal. A Gadolinium(III)‐based MRI contrast agent is presented that undergoes a significant change in relaxivity (25%) upon uncaging, providing a reliable indicator of light‐induced cargo release. Additionally, we introduce the first light‐responsive CEST‐MRI imaging agent, enabling positive signal enhancement (off‐to‐on) upon light activation, offering a novel approach to visualize the activation of photoactive agents in living tissues. This research provides a proof‐of‐principle for the non‐invasive, whole‐body imaging of light penetration and drug activation with high temporal resolution characteristic of MR methods.
- 1 June 2024
- Published by Wiley in Smart Molecules
- Vol. 2 (2)
Open AccessTowards medical imaging of drug photoactivation: Development of light responsive magnetic resonance imaging and chemical exchange saturation transfer contrast agents
In recent years, the use of light to selectively and precisely activate drugs has been developed along the fundamental concepts of photopharmacology. One of the key methods in this field relies on transiently silencing the drug activity with photocleavable protecting groups (PPGs). To effectively utilize light‐activated drugs in future medical applications, physicians will require a reliable method to assess whether light penetrates deep enough into the tissues to activate the photoresponsive theragnostic agents. Here, we describe the development and evaluation of magnetic resonance (MR) imaging agents that allow for the detection of light penetration and drug activation in the tissues using non‐invasive whole‐body magnetic resonance imaging (MRI) and chemical exchange saturation transfer (CEST)‐MRI modalities. The approach relies on the use of PPG‐protected MR contrast agents, which upon irradiation with light change their imaging signal. A Gadolinium(III)‐based MRI contrast agent is presented that undergoes a significant change in relaxivity (25%) upon uncaging, providing a reliable indicator of light‐induced cargo release. Additionally, we introduce the first light‐responsive CEST‐MRI imaging agent, enabling positive signal enhancement (off‐to‐on) upon light activation, offering a novel approach to visualize the activation of photoactive agents in living tissues. This research provides a proof‐of‐principle for the non‐invasive, whole‐body imaging of light penetration and drug activation with high temporal resolution characteristic of MR methods.
- 21 May 2024
- Published by University of Groningen Press
Photoactivation of Molecular Function
- Open Access
- 5 January 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 15 (6) , 2062-2073
The fate of the contact ion pair determines the photochemistry of coumarin-based photocleavable protecting groups
Photocleavable protecting groups (PPGs) enable the precise spatiotemporal control over the release of a payload of interest, in particular a bioactive substance, through light irradiation. A crucial parameter that determines the practical applicability of PPGs is the efficiency of payload release, largely governed by the quantum yield of photolysis (QY). Understanding which parameters determine the QY will prove crucial for engineering improved PPGs and their effective future applications, especially in the emerging field of photopharmacology. The Contact Ion Pair (CIP) has been recognized as an important intermediate in the uncaging process, but the key influence of its fate on the quantum yield has not been explored yet, limiting our ability to design improved PPGs. Here, we demonstrate that the CIP escape mechanism of PPGs is crucial for determining their payload- and solvent-dependent photolysis QY, and illustrate that an intramolecular type of CIP escape is superior over diffusion-dependent CIP escape. Furthermore, we report a strong correlation of the photolysis QY of a range of coumarin PPGs with the DFT-calculated height of all three energy barriers involved in the photolysis reaction, despite the vastly different mechanisms of CIP escape that these PPGs exhibit. Using the insights obtained through our analysis, we were able to predict the photolysis QY of a newly designed PPG with particularly high accuracy. The level of understanding of the factors determining the QY of PPGs presented here will move the ever-expanding field of PPG applications forward and provides a blueprint for the development of PPGs with QYs that are independent of payload-topology and solvent polarity.
- 5 January 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 15 (6) , 2062-2073
Open AccessThe fate of the contact ion pair determines the photochemistry of coumarin-based photocleavable protecting groups
Photocleavable protecting groups (PPGs) enable the precise spatiotemporal control over the release of a payload of interest, in particular a bioactive substance, through light irradiation. A crucial parameter that determines the practical applicability of PPGs is the efficiency of payload release, largely governed by the quantum yield of photolysis (QY). Understanding which parameters determine the QY will prove crucial for engineering improved PPGs and their effective future applications, especially in the emerging field of photopharmacology. The Contact Ion Pair (CIP) has been recognized as an important intermediate in the uncaging process, but the key influence of its fate on the quantum yield has not been explored yet, limiting our ability to design improved PPGs. Here, we demonstrate that the CIP escape mechanism of PPGs is crucial for determining their payload- and solvent-dependent photolysis QY, and illustrate that an intramolecular type of CIP escape is superior over diffusion-dependent CIP escape. Furthermore, we report a strong correlation of the photolysis QY of a range of coumarin PPGs with the DFT-calculated height of all three energy barriers involved in the photolysis reaction, despite the vastly different mechanisms of CIP escape that these PPGs exhibit. Using the insights obtained through our analysis, we were able to predict the photolysis QY of a newly designed PPG with particularly high accuracy. The level of understanding of the factors determining the QY of PPGs presented here will move the ever-expanding field of PPG applications forward and provides a blueprint for the development of PPGs with QYs that are independent of payload-topology and solvent polarity.